Objective To investigate the relationship between the intercellular transmission efficiency of human T-lymphotropic virus type I (HTLV-I) and the signaling involved in actin polymerization during cytoskeletal reorganization in a comparative study of HTLV-I-infected T-cell lines derived from an HTLV-Iassociated myelopathy/tropical spastic paraparesis (HAM/TSP) patient or an HTLV-I carrier.
Introduction
Human T-lymphotropic virus type I (HTLV-I) infects cells by intercellular transmission through the virological synapse, which is composed of integrin/ligand complexes, such as lymphocyte function antigen-1 (aLb2)/intercellular adhesion molecule-1 (ICAM-1), and mediates cytoskeletal polarization. [1] [2] [3] Integrin/ ligand signaling induces the activation of small GTPases, such as Rho, Rac and Cdc42, and subsequently regulates cytoskeletal reorganization including actin polymerization, cell polarity and reorientation of the microtubule-organizing center. [4] [5] [6] Therefore, it can be speculated that the status of cytoskeletal reorganization determines the intercellular transmission efficiency of HTLV-I. We previously reported that Rac and Cdc42 are more activated in HTLV-I-infected T-cell lines derived from HAM/TSP patients than in those derived from other origins, 7 suggesting that HTLV-I-infected T-cell lines derived from HAM/TSP patients have the potential of the efficient intercellular transmission of HTLV-I based on activated status of the cytoskeletal reorganization including actin polymerization.
The vasodilator-stimulated phosphoprotein (VASP) regulates signal transduction pathways involved in actin cytoskeleton dynamics. 8, 9 VASP is a known substrate of serine/threonine kinases, such as cyclic adenosine monophosphate-(cAMP) or cyclic guanosine monophosphate (cGMP)-dependent protein kinase (PKA or PKG, respectively). Both kinases phosphorylate the Ser 157 and Ser 239 sites in VASP. It is known that phosphorylated VASP (p-VASP) acts as a negative regulator of actin dynamics. Phosphorylation of VASP catalyzed by either PKA or PKG inhibits actin polymerization, and conversely, dephosphorylation accelerates actin polymerization. That is, the degree of reorganization of the actin cytoskeleton is determined by the phosphorylated or dephosphorylated status of VASP. Therefore, the intracellular cAMP or cGMP concentration might regulate polarization of the actin cytoskeleton and affect the intercellular transmission efficiency of HTLV-I.
To test these hypotheses, we investigated the relationships between the intercellular transmission efficiency of HTLV-I, the intracellular cAMP or cGMP levels and the phosphorylation status of VASP in a comparative study of HTLV-I-infected T-cell lines derived from an HAM/TSP patient or an HTLV-I carrier.
Methods

Chemicals and antibodies
Latrunclin B was purchased from Enzo Life Sciences (Plymouth Meeting, PA, USA). Forskolin was purchased from Applichem (Darmstadt, Germany). Both compounds were dissolved with dimethyl sulfoxide (DMSO) as the vehicle before experiments. Rabbit polyclonal anti-VASP, phosphorylated VASP (Ser 157 or Ser 239 ; p-VASP), rabbit monoclonal anti-glyceraldehyde 3-phosphate dehydrogenase (GAPDH), and horseradish peroxidase (HRP)-conjugated goat anti-rabbit immunoglobulin G antibody were purchased from Cell Signaling Technology (Beverly, MA, USA). Mouse monoclonal anti-HTLV-I tax or gp-46, a-tubulin and an HRP-conjugated goat anti-mouse immunoglobulin G antibody were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA).
Cell lines
Interleukin-2 (IL-2)-dependent HTLV-I-infected T-cell line derived from the cerebrospinal fluid of an HAM/TSP patient (HCT-5) and IL-2-independent HTLV-I-infected T-cell line derived from an HTLV-I carrier (TL-Su) were used in the present study. 7 The H9/K30 luc reporter cell line was kindly provided by Professor Akio Adachi (University of Tokushima Graduate School, Tokushima, Japan). H9/K30 luc cells are lymphocytic H9 cells that have been stably transfected with a plasmid containing the gene encoding luciferase under the control of the HTLV-I long terminal repeat (LTR). 10 Therefore, as activation of LTR driven by HTLV-I tax induces luciferase expression, these reporter cells can detect the efficiency of HTLV-I transmission under co-cultivation with HTLV-I-infected cells by a luciferase assay system. Expression of the integrin aLb2 and its ligand, ICAM-1, was confirmed in both cell lines by flow cytometric analysis.
The present study complied with the guidelines of the ethics committee of our institution.
Western blotting analysis
Each culture of HTLV-I-infected T cells was collected and lysed by the addition of M-PER mammalian protein extraction reagent (Thermo Scientific, Hanover Park, IL, USA) supplemented with a protease inhibitor cocktail (Sigma-Aldrich, St, Louis, MO, USA) and a Halt phosphatase inhibitor cocktail (Thermo Scientific). Insoluble material was removed by centrifugation at 14 300 g for 30 min at 4°C, and the supernatant was analyzed by western blotting. An identical amount of protein for each lysate (20 lg) was subjected to 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (ATTO, Tokyo, Japan). Subsequently, proteins were transferred onto a polyvinylidene difluoride membrane and immersed in 5% non-fat milk in Tris-buffered saline, 0.1% Tween 20 (TBST) at room temperature for 60 min to block non-specific binding sites. Anti-p-VASP, -VASP, -HTLV-I tax and -HTLV-I gp46 (all used at 1:1000 dilution) antibodies were used as primary detection reagents. Anti-GAPDH or a-tubulin (both used at 1:1000 dilution) antibodies for detection of an internal control protein were used for confirmation of equal protein loading. Membranes were incubated overnight with specific primary antibodies at 4°C. After washing with TBST, membranes were incubated with appropriate secondary HRP-conjugated anti-species antibodies at room temperature for 1 h. After further washing with TBST, peroxidase activity was detected by using the ECL plus western blot detection system (Amersham, GE Healthcare, Little Chalfont, UK).
Measurement of intracellular cAMP or cGMP levels
Intracellular cAMP or cGMP levels in both cell lines were measured using enzyme-linked immunoassay kits [cyclic AMP complete assay (Stressgen, Ann Arbor, MI, USA) or Paramete cyclic GMP assay (R&D systems, Minneapolis, MN, USA), respectively], according to the instructions provided by the manufacturer. Briefly, equal numbers of HCT-5 or TL-Su cells and equal numbers of DMSO-or forskolin-treated HCT-5 were lysed with an equal volume of lysis buffer. After uniform lysis was confirmed by microscopy, the cellular debris was removed by centrifugation at 600 g for 10 min at 4°C, and the supernatant was used for assays. The intracellular cAMP or cGMP levels were determined in triplicate. Data were expressed as mean AE SD. The minimum detection limits of cAMP and cGMP in these assays were 0.039 pmol/mL or 1.14 pmol/mL, respectively.
Co-cultivation
HCT-5 or TL-Su (5 9 10 5 cells) were co-cultivated with H9/K30 luc reporter cells (3.5 9 10 5 cells; kindly provided by Professor Akio Adachi, University of Tokushima Graduate School) in a 24-well culture plate at 37°C under 5% CO 2 . After co-cultivation for 6 h, luciferase activity was assessed by using a luciferase assay system (Promega, Madison, WI, USA) and Gene Light (Microtec, Tokyo, Japan). The relative luc activity was calculated according to the following formula: relative luminescent units (RLU) of co-cultivated sample/RLU of the H9 only cultivated sample. Data were expressed as mean AE SD of triplicate cultures.
Latrunclin B and forskolin treatment
Latrunclin B disrupts the actin cytoskeleton of cells by inhibiting actin polymerization. 11 Forskolin induces increased intracellular cAMP levels by activation of adenylyl cyclase. 12 HCT-5 cells were treated with 1.25 lmol/L latrunculin B or 15 lmol/L forskolin or DMSO. Treated HCT-5 cells were lysed at intervals up to 6 h for western blotting analysis and an assay of intracellular cAMP or cGMP levels. Concomitantly, after treatment for 90 min, HCT-5 cells were co-cultivated with H9/K30 luc cells. Analysis of cell viability using a modified MTT assay, MTS (Promega), showed that treatment with both compounds for up to 6 h was not associated with toxicity in either H9/K30 luc or HCT-5 cells.
Statistical analysis
Student's t-tests were used for statistical analysis. Differences were considered significant at P < 0.05.
Results
Effect of latrunculin B treatment on the intercellular transmission efficiency of HTLV-I
The relationship between the intercellular transmission efficiency of HTLV-I and actin polymerization was first analyzed. As shown in Fig. 1a , treatment of HCT-5 cells with latrunculin B significantly suppressed (approximately 70%) the relative luc activity (DMSO treated: 6.7 AE 0.3 vs latrunculin B treated: 2 AE 0.1, P = 0.0014) without downregulation of the expression of HTLV-I tax and gp46 (Fig. 1b) . These observations suggest that actin reorganization plays an important role in the intercellular transmission of HTLV-I.
Relationship between the intracellular cAMP concentration and the efficiency of the intercellular transmission of HTLV-I
Forskolin treatment of HCT-5 induced a significant increase in the intracellular cAMP concentration (DMSO treated, forskolin treated: 5.37 AE 0.47, 42.90 AE 0.95 pmol/mL, respectively, P = 0.0047; Fig. 2a ). Concomitantly, upregulation of p-VASP (Ser 157 ) was observed by western blotting analysis (Fig. 2b) . However, there were no differences in the expression of HTLV-I tax and gp46 between DMSO and forskolin treatment (Fig. 2b) . As shown in Fig. 2c , analysis of the intercellular transmission efficiency of HTLV-I revealed a decrease in relative luc activity to 50% in forskolin-treated HCT-5 (3 AE 0.5), compared with DMSO-treated HCT-5 cells (6 AE 0.9; P = 0.0299).
Comparative analysis of intracellular cAMP concentrations, p-VASP expression, and the intercellular transmission efficiency of HTLV-I between HCT-5 and TL-Su
As shown in Fig. 3a , the intracellular cAMP level was significantly lower in HCT-5 (2.67 AE 0.50 pmol/ mL) than in TL-Su (11.58 AE 2.47 pmol/mL; P = 0.0240), although there was no significant difference in the intracellular cGMP levels between the cell lines (HCT-5, TL-Su; 5.02 AE 1.46, 4.86 AE 0.57 pmol/mL, respectively, P = 0.9023). Consistent with this result, VASP appeared to be less phosphorylated in HCT-5 than in TL-Su (Fig. 3b ). Comparison of the intercellular transmission efficiency of HTLV-I showed that the relative luc activity was significantly higher in HCT-5 (7.1 AE 1.3) than that in TL-Su (1.1 AE 0.1; P = 0.0156). These data show the higher intercellular transmission efficiency of HTLV-1 of HCT-5 compared with that of TL-Su (Fig. 3c) .
Discussion
In the present study, we showed that intracellular cAMP regulates the efficiency of intercellular transmission of HTLV-I through control of VASP phosphorylation in HTLV-I-infected cells. The present results suggested that the reorganization of actin, which is a major component of the cytoskeleton, plays an important role in HTLV-I transmission.
However, the absence of any significant difference in the intracellular cGMP concentrations between HCT-5 and TL-Su cells indicates that intracellular cGMP, which is also involved in VASP phosphorylation through PKG, does not influence the efficiency of HTLV-I transmission. To our knowledge, this is the first report of signaling molecule involvement in the efficacy of intercellular transmission of HTLV-I. It is well known that a high HTLV-I proviral load in the peripheral blood is the most important prerequisite for the development of HAM/TSP. 13, 14 Factors such as the relatively lower activity of HTLV-I-specific CD8+ cytotoxic T cells against HTLV-Iinfected CD4+ T cells 14 and the active replication of HTLV-I 15, 16 have been proposed as reasons for the induction of high HTLV-I proviral load in HAM/TSP patients. However, the increased proliferation of HTLV-I-infected cells 3, 17, 18 seems to play a highly important role in this effect, and it can be speculated that efficient intercellular transmission of HTLV-I is also partially responsible. Indeed, we previously reported that HTLV-I production by HAM/TSP patient-derived HTLV-I-infected T-cell lines, in which Rac and Cdc42 are activated, is downregulated by blockade of integrin/ligand interactions 7 , suggesting that the extracellular release of HTLV-I from these HTLV-I-infected T-cell lines depends on the reorganization status of the cytoskeleton after activation of integrin/ligand signaling. Therefore, HAM/ TSP-derived HTLV-I-infected T-cell lines might have the activity of efficient intercellular transmission of HTLV-I. Indeed, in the present study, we showed that HCT-5 cells have the activity of efficient intercellular transmission of HTLV-I with downregulated p-VASP expression following downregulation of intracellular cAMP level compared with TL-Su cells. Although this observation requires confirmation in other HTLV-I-infected T-cell lines, it suggests that HTLV-I-infected cells in HAM/TSP patients have the potential for efficient transmission of HTLV-I to noninfected cells, and its potential is partially responsible for the induction of a high HTLV-I proviral load in the peripheral blood observed in HAM/TSP patients.
Interestingly, the intracellular cAMP concentration was found to be lower in an HTLV-I-infected T-cell line derived from an HAM/TSP patient than that in an HTLV-I carrier derived T-cell line. Recently, Kress et al. reported that cAMP levels are elevated by decreased expression of phosphodiesterase, which hydrolyzes the phosphodiester bond in cAMP, in HTLV-I-infected transformed T-cell lines derived from patients with adult T-cell leukemia. 19 Thus, the regulation of intracellular cAMP level might be different among HTLV-I-infected T-cell lines from HAM/TSP patients, HTLV-I carriers and adult T-cell leukemia patients.
The reorganization of actin is also involved in cell adhesion and migration. 20, 21 We previously reported the increased adherent activity of peripheral blood CD4+ T cells of HAM/TSP patients to human endothelial cells. 22 Subsequently, we showed the heightened transmigrating activity of peripheral blood HTLV-I-infected T cells through a reconstituted basement membrane in HAM/TSP patients. 23 The low levels of intracellular cAMP in HTLV-I-infected T cells in HAM/TSP patients might induce a tendency toward the reorganization of actin, thus accounting for the increased adhesion and transmigrating activities of HTLV-I-infected T cells in HAM/ TSP patients.
In conclusion, we showed that the intracellular cAMP concentration regulates the efficiency of intercellular HTLV-I transmission through the regulation of VASP phosphorylation. Further investigations of the signaling molecules and pathways involved in the regulation of the intracellular cAMP concentrations in HTLV-I-infected T cells are required to elucidate the mechanisms underlying this effect. In addition, based on the results of a comparative study between HTLV-I-infected T-cell lines derived from an HAM/TSP patient and an HTLV-I carrier in the present study, comparative studies of peripheral blood HTLV-Iinfected T cells in HAM patients and HTLV-I carriers are required to confirm our observations.
